Cargando…
Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma
BACKGROUND: Anastomotic stenosis and leakage are rare complications after esophagojejunostomy. The management of complications after esophagojejunostomy remains a challenge. We evaluated the outcomes and clinical effectiveness of an alternative interventional protocol. OBJECTIVES: To determine the s...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913380/ https://www.ncbi.nlm.nih.gov/pubmed/31871443 http://dx.doi.org/10.1155/2019/1465301 |
_version_ | 1783479650992783360 |
---|---|
author | Bi, Yonghua Li, Jindong Yi, Mengfei Yu, Zepeng Han, Xinwei Ren, Jianzhuang |
author_facet | Bi, Yonghua Li, Jindong Yi, Mengfei Yu, Zepeng Han, Xinwei Ren, Jianzhuang |
author_sort | Bi, Yonghua |
collection | PubMed |
description | BACKGROUND: Anastomotic stenosis and leakage are rare complications after esophagojejunostomy. The management of complications after esophagojejunostomy remains a challenge. We evaluated the outcomes and clinical effectiveness of an alternative interventional protocol. OBJECTIVES: To determine the safety and efficacy of interventional treatment for the management of complications after esophagojejunostomy. METHODS: This study included 24 consecutive patients with complications after esophagojejunostomy treated using interventional protocol. Patients received balloon dilation or stenting for anastomotic stenosis. Patients with anastomotic leakage received three-tube placement or retrievable covered esophageal stent placement, followed by abscess drainage, nutritional support, and anti-inflammatory treatment. The three tubes and esophageal stents were removed after leakage healing and stenosis ceased. RESULTS: Thirteen patients received three-tube method, and 16 patients received covered stent placement. All procedures were technically successful, except for a failure of Y-type esophageal stent placement in one patient. The median retention time of stent and abscess drainage tube was 67.5 days and 87 days, respectively. No perioperative death, esophageal rupture, or massive hemorrhage was found during procedures. During follow-up, 14 patients died of cancer recurrence, and one died of severe pulmonary infection. The 1-, 3-, 5-year survival rates were 39.5%, 23.7%, and 23.7%, respectively. CONCLUSION: Interventional protocol is safe, feasible, and efficacious for treatment of complications after esophagojejunostomy. |
format | Online Article Text |
id | pubmed-6913380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-69133802019-12-23 Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma Bi, Yonghua Li, Jindong Yi, Mengfei Yu, Zepeng Han, Xinwei Ren, Jianzhuang Gastroenterol Res Pract Clinical Study BACKGROUND: Anastomotic stenosis and leakage are rare complications after esophagojejunostomy. The management of complications after esophagojejunostomy remains a challenge. We evaluated the outcomes and clinical effectiveness of an alternative interventional protocol. OBJECTIVES: To determine the safety and efficacy of interventional treatment for the management of complications after esophagojejunostomy. METHODS: This study included 24 consecutive patients with complications after esophagojejunostomy treated using interventional protocol. Patients received balloon dilation or stenting for anastomotic stenosis. Patients with anastomotic leakage received three-tube placement or retrievable covered esophageal stent placement, followed by abscess drainage, nutritional support, and anti-inflammatory treatment. The three tubes and esophageal stents were removed after leakage healing and stenosis ceased. RESULTS: Thirteen patients received three-tube method, and 16 patients received covered stent placement. All procedures were technically successful, except for a failure of Y-type esophageal stent placement in one patient. The median retention time of stent and abscess drainage tube was 67.5 days and 87 days, respectively. No perioperative death, esophageal rupture, or massive hemorrhage was found during procedures. During follow-up, 14 patients died of cancer recurrence, and one died of severe pulmonary infection. The 1-, 3-, 5-year survival rates were 39.5%, 23.7%, and 23.7%, respectively. CONCLUSION: Interventional protocol is safe, feasible, and efficacious for treatment of complications after esophagojejunostomy. Hindawi 2019-12-01 /pmc/articles/PMC6913380/ /pubmed/31871443 http://dx.doi.org/10.1155/2019/1465301 Text en Copyright © 2019 Yonghua Bi et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Bi, Yonghua Li, Jindong Yi, Mengfei Yu, Zepeng Han, Xinwei Ren, Jianzhuang Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma |
title | Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma |
title_full | Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma |
title_fullStr | Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma |
title_full_unstemmed | Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma |
title_short | Interventional Protocol for Treatment of Complications after Esophagojejunostomy for Esophagogastric Carcinoma |
title_sort | interventional protocol for treatment of complications after esophagojejunostomy for esophagogastric carcinoma |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913380/ https://www.ncbi.nlm.nih.gov/pubmed/31871443 http://dx.doi.org/10.1155/2019/1465301 |
work_keys_str_mv | AT biyonghua interventionalprotocolfortreatmentofcomplicationsafteresophagojejunostomyforesophagogastriccarcinoma AT lijindong interventionalprotocolfortreatmentofcomplicationsafteresophagojejunostomyforesophagogastriccarcinoma AT yimengfei interventionalprotocolfortreatmentofcomplicationsafteresophagojejunostomyforesophagogastriccarcinoma AT yuzepeng interventionalprotocolfortreatmentofcomplicationsafteresophagojejunostomyforesophagogastriccarcinoma AT hanxinwei interventionalprotocolfortreatmentofcomplicationsafteresophagojejunostomyforesophagogastriccarcinoma AT renjianzhuang interventionalprotocolfortreatmentofcomplicationsafteresophagojejunostomyforesophagogastriccarcinoma |